Controversy Over Zembig and Were Govey

This chapter explores the controversy surrounding the drugs Zembig and Were Govey, approved for diabetes and obesity treatment, and their impact on insulin regulation and appetite suppression. It delves into the high demand, cost, off-label use, and global shortage issues, raising concerns about safety and the allure of rapid weight loss despite potential risks.